153 related articles for article (PubMed ID: 34415055)
21. PD-L1 expression in tumour-infiltrating lymphocytes is a poor prognostic factor for primary acral melanoma patients.
Ren M; Dai B; Kong YY; Lv JJ; Cai X
Histopathology; 2018 Sep; 73(3):386-396. PubMed ID: 29637587
[TBL] [Abstract][Full Text] [Related]
22. Tumor-infiltrating lymphocyte response in cutaneous melanoma in the elderly predicts clinical outcomes.
Grotz TE; Vaince F; Hieken TJ
Melanoma Res; 2013 Apr; 23(2):132-7. PubMed ID: 23344159
[TBL] [Abstract][Full Text] [Related]
23. Prognostic Significance of Primary Tumor-Infiltrating Lymphocytes in a Contemporary Melanoma Cohort.
Straker RJ; Krupp K; Sharon CE; Thaler AS; Kelly NJ; Chu EY; Elder DE; Xu X; Miura JT; Karakousis GC
Ann Surg Oncol; 2022 Aug; 29(8):5207-5216. PubMed ID: 35301610
[TBL] [Abstract][Full Text] [Related]
24. Impact of Tumor-Infiltrating Lymphocytes on Overall Survival in Merkel Cell Carcinoma.
Butala AA; Jain V; Reddy VK; Sebro RA; Song Y; Karakousis G; Mitchell TC; Lukens JN; Shabason JE
Oncologist; 2021 Jan; 26(1):63-69. PubMed ID: 32886418
[TBL] [Abstract][Full Text] [Related]
25. TRIM27 expression is associated with poor prognosis in sinonasal mucosal melanoma.
Kimura S; Suzuki M; Nakamaru Y; Kano S; Watanabe M; Honma A; Nakazono A; Tsushima N; Hatakeyama S; Homma A
Rhinology; 2023 Jun; 61(3):263-271. PubMed ID: 36891983
[TBL] [Abstract][Full Text] [Related]
26. CD8⁺ tumor-infiltrating lymphocytes at primary sites as a possible prognostic factor of cutaneous angiosarcoma.
Fujii H; Arakawa A; Utsumi D; Sumiyoshi S; Yamamoto Y; Kitoh A; Ono M; Matsumura Y; Kato M; Konishi K; Shiga T; Sano S; Sakaguchi S; Miyagawa-Hayashino A; Takahashi K; Uezato H; Miyachi Y; Tanioka M
Int J Cancer; 2014 May; 134(10):2393-402. PubMed ID: 24243586
[TBL] [Abstract][Full Text] [Related]
27. Deep learning-based scoring of tumour-infiltrating lymphocytes is prognostic in primary melanoma and predictive to PD-1 checkpoint inhibition in melanoma metastases.
Chatziioannou E; Roßner J; Aung TN; Rimm DL; Niessner H; Keim U; Serna-Higuita LM; Bonzheim I; Kuhn Cuellar L; Westphal D; Steininger J; Meier F; Pop OT; Forchhammer S; Flatz L; Eigentler T; Garbe C; Röcken M; Amaral T; Sinnberg T
EBioMedicine; 2023 Jul; 93():104644. PubMed ID: 37295047
[TBL] [Abstract][Full Text] [Related]
28. Treatment modalities in sinonasal mucosal melanoma: A national cancer database analysis.
Ganti A; Raman A; Shay A; Kuhar HN; Auger SR; Patel T; Kuan EC; Diaz AZ; Batra PS; Tajudeen BA
Laryngoscope; 2020 Feb; 130(2):275-282. PubMed ID: 31021415
[TBL] [Abstract][Full Text] [Related]
29. Primary tumor volume as a predictor of distant metastases and survival in patients with sinonasal mucosal melanoma.
Flukes S; Lohia S; Barker CA; Cracchiolo JR; Ganly I; Patel SG; Roman BR; Shah JP; Shoushtari AN; Tabar V; Shah A; Cohen MA
Head Neck; 2020 Nov; 42(11):3316-3325. PubMed ID: 32737953
[TBL] [Abstract][Full Text] [Related]
30. Tumor Infiltrating Lymphocytes (TILs) May be Only an Independent Predictor of Nodal Involvement but not for Recurrence and Survival in Cutaneous Melanoma Patients.
Tas F; Erturk K
Cancer Invest; 2017 Sep; 35(8):501-505. PubMed ID: 28799813
[TBL] [Abstract][Full Text] [Related]
31. Nodal and distant metastases in sinonasal mucosal melanoma: A population-based analysis.
Low CM; Price DL; Moore EJ; Stokken JK; Van Abel KM; Janus JR; Choby G
Laryngoscope; 2020 Mar; 130(3):622-627. PubMed ID: 31077407
[TBL] [Abstract][Full Text] [Related]
32. Clinical and histopathological risk factors to predict sentinel lymph node positivity, disease-free and overall survival in clinical stages I-II AJCC skin melanoma: outcome analysis from a single-institution prospectively collected database.
Mandalà M; Imberti GL; Piazzalunga D; Belfiglio M; Labianca R; Barberis M; Marchesi L; Poletti P; Bonomi L; Novellino L; Di Biagio K; Milesi A; Guerra U; Tondini C
Eur J Cancer; 2009 Sep; 45(14):2537-45. PubMed ID: 19553103
[TBL] [Abstract][Full Text] [Related]
33. The role of tumor-infiltrating lymphocytes (TILs) as a predictive biomarker of response to anti-PD1 therapy in patients with metastatic non-small cell lung cancer or metastatic melanoma.
Uryvaev A; Passhak M; Hershkovits D; Sabo E; Bar-Sela G
Med Oncol; 2018 Jan; 35(3):25. PubMed ID: 29388007
[TBL] [Abstract][Full Text] [Related]
34. Tumor infiltrating lymphocytes in acral lentiginous melanoma: a study of a large cohort of cases from Latin America.
Castaneda CA; Torres-Cabala C; Castillo M; Villegas V; Casavilca S; Cano L; Sanchez J; Dunstan J; Calderon G; De La Cruz M; Cotrina JM; Gomez HL; Galvez R; Abugattas J
Clin Transl Oncol; 2017 Dec; 19(12):1478-1488. PubMed ID: 28577153
[TBL] [Abstract][Full Text] [Related]
35. Oncologic outcomes, prognostic factor analysis and therapeutic algorithm evaluation of head and neck mucosal melanomas in France.
Moya-Plana A; Aupérin A; Obongo R; Baglin A; Ferrand FR; Baujat B; Saroul N; Casiraghi O; Vergez S; Herman P; Janot F; Thariat J; Vérillaud B; de Gabory L;
Eur J Cancer; 2019 Dec; 123():1-10. PubMed ID: 31670075
[TBL] [Abstract][Full Text] [Related]
36. Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma.
Clemente CG; Mihm MC; Bufalino R; Zurrida S; Collini P; Cascinelli N
Cancer; 1996 Apr; 77(7):1303-10. PubMed ID: 8608507
[TBL] [Abstract][Full Text] [Related]
37. Surgical Margin Status and Survival Following Resection of Sinonasal Mucosal Melanoma.
Elsamna ST; Ahsanuddin S; Mir GS; Sukyte-Raube D; Fang CH; Baredes S; Eloy JA
Laryngoscope; 2021 Nov; 131(11):2429-2435. PubMed ID: 33864635
[TBL] [Abstract][Full Text] [Related]
38. Association Between NRAS and BRAF Mutational Status and Melanoma-Specific Survival Among Patients With Higher-Risk Primary Melanoma.
Thomas NE; Edmiston SN; Alexander A; Groben PA; Parrish E; Kricker A; Armstrong BK; Anton-Culver H; Gruber SB; From L; Busam KJ; Hao H; Orlow I; Kanetsky PA; Luo L; Reiner AS; Paine S; Frank JS; Bramson JI; Marrett LD; Gallagher RP; Zanetti R; Rosso S; Dwyer T; Cust AE; Ollila DW; Begg CB; Berwick M; Conway K;
JAMA Oncol; 2015 Jun; 1(3):359-68. PubMed ID: 26146664
[TBL] [Abstract][Full Text] [Related]
39. Histologic classification of tumor-infiltrating lymphocytes in primary cutaneous malignant melanoma. A study of interobserver agreement.
Busam KJ; Antonescu CR; Marghoob AA; Nehal KS; Sachs DL; Shia J; Berwick M
Am J Clin Pathol; 2001 Jun; 115(6):856-60. PubMed ID: 11392882
[TBL] [Abstract][Full Text] [Related]
40. Tumor-infiltrating lymphocyte grade is an independent predictor of sentinel lymph node status and survival in patients with cutaneous melanoma.
Azimi F; Scolyer RA; Rumcheva P; Moncrieff M; Murali R; McCarthy SW; Saw RP; Thompson JF
J Clin Oncol; 2012 Jul; 30(21):2678-83. PubMed ID: 22711850
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]